Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Capital Reinvestment Ratio
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Capital Reinvestment Ratio of 0.51x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥3.56 Million) in capital expenditures (CN¥1.81 Million). Check 688488 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Aidea Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Jiangsu Aidea Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Jiangsu Aidea Pharmaceutical Co Ltd (688488) cash conversion ratio.
Annual Capital Reinvestment Ratio for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. See 688488 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.72x | CN¥17.63 Million | CN¥47.93 Million | ▲ +259.9% |
| 2020 | 0.76x | CN¥56.17 Million | CN¥42.43 Million | ▲ +26.7% |
| 2019 | 0.60x | CN¥56.20 Million | CN¥33.50 Million | ▼ -73.7% |
| 2016 | 2.27x | CN¥31.29 Million | CN¥71.01 Million | — |